4 employees
META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.
2021
$15M
from 4 investors over 4 rounds
META Pharmaceuticals Inc. raised $15M on June 13, 2022
Investors: New Industry Ventures Venture Capital Fund, Tiantu Capital, XtalPi Inc. and IMO Ventures